| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82652-90 | | | | | M125V | 8/3/2018 | | | | 1.5 mL blood (0.7 mL serum) | 8/3/2018 11:18 AM |  Jaime Desantiago | | 1,25 VITD | | | | | | 3.0 mL blood (1.5 mL serum) | | Vitamin D (1,25-Dihydroxy, Calcifidol) | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83491-90, 82570-90 | | | Refrigerate during collection | | U17HC | 05/16/17 | | | | Submit entire urine collection to the laboratory. | 5/16/2017 10:44 AM | Mira Davis | | URT 17- HYDROXY CORTICOSTEROIDS; U/17-CS | | | | | | | | 17-OH Corticosteroids; 17-OHCS; Porter-Silber Chromogens, Urine; Urine 17-OH Corticosteroids | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | 3181222 | | Item | 83498-90 | | | | | 17-OHPR-NB | 4-13-2015 | | | RIA | 0.5 mL blood (0.25 mL serum) | 4/13/2015 9:04 AM | Melody I Adams | | 17-OH Progesteron (<1 YR) | | | | | | 1.0 mL blood (0.5 mL serum) | Separate test available for patients older than 1 year. | 17-OH Progesterone, Newborn | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83498-90 | | | | | PROGS | 8/3/2018 | | | | | 8/15/2018 9:06 AM | Mira Davis | | 17-OH PROG | | | | | | 2.0 mL blood (1.0 mL serum) | Separate test available for patients younger than 1 year. | 17-OH Progesterone | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83586-90, 82570-90 | | | Refrigerate during collection | | U17KS | 05/16/17 | | | | | 5/16/2017 10:41 AM | Mira Davis | | URT 17 KETOSTEROIDS TOTAL; U/17KS | | | | | | | | 17-KS; Urine 17-Ketosteroids | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 84143-90 | | | | | PREGN | 8/3/2018 | | | | 1.0 mL blood (0.4 mL serum) | 8/3/2018 11:18 AM | Jaime Desantiago | | | | | | | | 2.0 mL blood (1.0 mL serum) | | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83498-90 | | | | | 17OHPROGPD | 1-24-2014 | | | | 0.5 mL blood (0.25 mL serum) | 2/5/2015 3:45 PM | System Account | | | | | | | | 1.0 mL blood (0.5 mL serum) | | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82306-90 | | | | | 25OHD | 6-14-2017 | | | | 1.0 mL blood (0.3 mL plasma) | 6/14/2017 10:48 AM | Mira Davis | | 25 OH VITD | | Deficient <20 ng/mL
Sub-Optimal 20-29 ng/mL
Optimal 30-80 ng/mL
Potential toxicity >150 ng/mL | | | | 2.0 mL blood (0.5 mL plasma) | | Vitamin D, 25-Hydroxy (25-OH) Total | |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83915-90 | | | | | 5NUC | 6-14-2017 | | | | 1.0 mL blood (0.2 mL serum) | 6/14/2017 10:50 AM | Mira Davis | | NUCLEOTIDASE 5; 5-NUC | | | | | | 2.0 mL blood (1.0 mL serum) | | Nucleotidase 5' | 5-7 working days |
| | Core Laboratory | | | | | Item | 85210; 85220; 85230; 85260; 85384; 85610; 85730; 85670 | PT >36 seconds
APTT >76 seconds
Fib <100 mg/dL
Plt <50 (1st time) <20 (every time)
| | Keep refrigerated. Separate plasma and freeze at -70°C if test is not performed promptly. Transport the specimen to the laboratory as soon as possible. Specimen MUST be received within 4 hours after collection. | | AQP | | | | | 3 mL blood, 1.5 mL plasma (per tube) | 2/5/2015 3:44 PM | System Account | | ABNORMAL QUICK PROFILE; AQP | | | | Specimen hemolyzed; Hct >65%; underfilled tube (QNS) | Transport the specimen to Specimen Receiving as soon as possible. Blood should arrive in the Coagulation Laboratory within 4 hours of drawing. | | Includes PT, APTT, Fibrinogen, Thrombin Time, Factors II, V, VII and X | AQP | 4 hours for PT, APTT, Fibrinogen and Thrombin Time
Factors II, V, VII and X are performed only 1600-2300.
|
| | Microbiology | BD ESWAB - Fluids/tissues may be submitted in a sterile container if transported to the laboratory immediately. | | | The specimen of choice is an aspirate or tissue, NOT a swab. Specimens are to be collected from a site prepared utilizing aseptic technique. Overlying and adjacent areas must be carefully prepared to eliminate surface (normal flora) anaerobes. Ideally, material is obtained by needle aspiration through an intact surface, which has been cleaned with antiseptic, then placed directly into the BBLTMPort-A-Cul Transport System. Sampling of open lesions is enhanced by deep aspiration using a sterile plastic catheter. Curetting of the base of an open lesion is optimal. If irrigation is necessary, nonbacteriostatic sterile saline may be used. When a syringe is used to obtain the specimen, ALL air should be expelled after which the specimen should be injected into a BBLTM | Item | 87075 | | | Avoid exposure to atmospheric oxygen. Specimen should be transported as soon as possible. When transportation is delayed, leave at room temperature. Do NOT refrigerate. | | C ANAEROBE | 3-10-2015 | A specimen received in anaerobic transport devices is not suitable for routine fungal or mycobacterial cultures. If more than three anaerobic isolates are present, the Bacteroides fragilis group and Clostridium perfringens will be the only isolates identified. Anaerobic susceptibility testing is NOT performed routinely. Should susceptibility testing be required, call the laboratory at (312) 942-5452. | | Conventional culture utilizing media specifically formulated for anaerobic isolation.
| 0.5 mL aspirate, small piece of tissue, or one swab | 3/10/2015 8:00 AM | Melody I Adams | | C ANAEROBE; CU ANAEROBIC
| | No growth of anaerobic bacteria | | Inappropriate specimen container, insufficient specimen volume, refrigerated specimen. Specimens from sites which have anaerobic bacteria as normal flora will routinely be rejected (i.e. vaginal, pharyngeal, etc.). | Avoid exposure to atmospheric oxygen. Specimens should be transported as soon as possible. When transportation is delayed, leave at room temperature. Do NOT refrigerate. The specific anatomic site of the abscess MUST be specified on the requisition with surface and/or deep or surgical abscesses delineated. | Aspirate, tissue, or other material appropriately obtained for anaerobic culture | Test includes culture for anaerobic organisms. Other isolated organisms (i.e. aerobes, yeast, etc.) may be referred for identification and/or susceptibility testing if medically indicated AND a separate culture procedure has NOT yielded the same organism(s). | Anaerobic Culture, Abscess | Cultures are examined every 48 hours. Preliminary reports are available after 48 hours. Culture reports of no growth will be issued after 5 days. Completion of culture reports may take 7-10 days after receipt of the specimen, depending upon the nature of the microorganisms isolated.
|
| | Core Laboratory | | | | | Item | 82003 | | | | | ACETM | 6-14-2017 | | | | 0.4 mL blood (0.2 mL serum) | 6/14/2017 11:11 AM | Mira Davis | | ACETOMINOPHEN; TYLENOL; ACETAMIN | | Therapeutic: 10-30 µg/mL | | | | | | Datril., Paracetamol; Tylenol. | Routine: 8 hours; stat: 1 hour |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83519-90 | | | | | ACHBI | 6-14-2017 | | | | 0.5 mL blood (0.2 mL serum) | 6/14/2017 11:13 AM | Mira Davis | | ACHR BINDING ANTIBODIES; ACHR BIND; ACHR | | | | Test will not be performed if patient had recent radioactive scan. | | 2 mL blood (1.0 mL serum) | | AChR Antibodies; Myasthenia Gravis Evaluation | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83519-90 | | | | | ACHBL | 6-14-2017 | | | | 0.5 mL blood (0.2 mL serum) | 6/14/2017 11:15 AM | Mira Davis | | ACHR BLOCKING ANTIBODY; ACHR BLOCK | | | | Test will not be performed if patient had recent radioactive scan. | | 2.0 mL blood (1.0 mL serum) | | Myasthenia Gravis Evaluation | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83519-90 | | | | | ACHMO | 9/6/17 | | | | 1.5 mL blood (0.8 mL serum) | 9/6/2017 11:08 AM | Sherry Bell | | ACHR MODULATING ANTIBODY; ACHR MODUL | | | | If patient had recent radioactive scan prior to collection of specimen. | | 4.0 mL blood (2.0 mL serum) | | Myasthenia Gravis Evaluation | |
| | Molecular Diagnostics/Genetics | | | | | Item | 82664-90 | | | If delayed delivery to the laboratory, refrigerate specimen. | | ACHE | | | | | | 2/5/2015 3:44 PM | System Account | | ACETYLCHOLINESTERASE; ACHE | | | | | | 3 mL amniotic fluid collected from 14-21 weeks gestation | | AChE, Amniotic Fluid; Amniotic Fluid Acetylcholinesterase; Gel AChE Test; Amniotic Fluid AChE | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 84066-90 | | | Avoid hemolysis. Due to the extremely unstable nature of the enzyme, the sample must be delivered to the laboratory immediately after collection. | | PAP | 9-17-2012 | | | | 1.0 mL blood (0.5 mL serum) | 2/5/2015 3:45 PM | System Account | | ACID PHOSPHATASE PROSTATIC; PAP(PROSTATIC ACID PHOSPHAT) | | | | | | 2.0 mL blood (1.0 mL serum) | | Acid Phos; AcP; Phosphatase, Acid; Prostatic Acid Phosphatase; PAP | 5-7 working days |
| | Microbiology | | Specimens from lesions suspected of containing Nocardia species should also be examined for fungi, mycobacteria, and Actinomyces species. Separate specimens should be submitted for Fungus Culture, Mycobacterium Culture, and Actinomycosis Special Anaerobic Culture. | | The specimen of choice is an aspirate, tissue, or lower respiratory specimen. Specimens are to be collected from a site prepared utilizing aseptic technique. Swabs should be used as a last resort. | Item | 87026 | | | Specimen should be transported as soon as possible. When transportation is delayed, refrigerate. | | SM AFB | 5-13-2014 | Nocardia species occasionally do NOT stain acid-fast with the Modified Acid-Fast stain. | | Modified Kinyoun stain
| | 2/5/2015 3:44 PM | System Account | | SM AFB
| | No acid-fast organisms resembling Nocardia species observed. | | Inappropriate specimen container; insufficient specimen volume. | Order or requisition MUST state smear for Nocardia. The specific anatomic site of the specimen MUST be specified on the order or requisition. | Pus or other purulent fluid material appropriately obtained from a wound; lower respiratory specimen. | Use to determine the presence or absence of organisms resembling Nocardia species which are generally acid-fast when stained by the modified acid-fast stain. Actinomyces species and Streptomyces species which may be microscopically similar to Nocardia species on Gram stain are not acid-fast with the modified acid-fast stain. | Nocardia, Acid-Fast Stain; Modified Acid-Fast Stain, Nocardia | Same day if received before 1430
|
| | Core Laboratory | | | | | Item | 85730 | | | Transport the specimen to the laboratory as soon as possible. Specimen MUST be received within 4 hours after collection. | | APTT | | | | | 3.5 mL blood (1.0 mL plasma); pediatric tubes must be fully drawn. | 11/17/2016 12:55 PM | Mira Davis | | ACTIVATED PTT; PTT | | | | Specimen hemolyzed; Hct >55%; underfilled tube (QNS) | Transport the specimen to Specimen Receiving as soon as possible. Blood should arrive in the Coagulation Laboratory within 4 hours of drawing. This test cannot be added onto an existing sample more than 4 hours old. | Blood; 4.5 mL tube or pediatric 1.8 mL or 2.7 mL tube | | APTT; Partial Thromboplastin Time; PTT | Routine: 4 hours. Stat: 1 hour |
| | Core Laboratory | | | | | Item | 85732 x3, 85703, 85670 | | | Transport the specimen to the laboratory as soon as possible. Specimen MUST be received within 4 hours after collection. | | PTTIN | 9/6/17 | | | | Two 2.7 mL draw blue tops
| 9/6/2017 11:06 AM | Sherry Bell | | APTT INHIBITOR; APTT INH | | No circulating anticoagulant identified. | | Specimen hemolyzed; Hct >55% | Transport the specimen to Specimen Receiving as soon as possible. Blood should arrive in the Coagulation Laboratory within 4 hours of drawing.This test cannot be added onto an existing sample more than 4 hours old. | Two 2.7 mL draw light blue top tubes
| Includes Thrombin Time to rule out heparin interference. | Activated Partial Thromboplastin Time Mixing Studies; APTT Inhibitor; APTT Mixing Studies; Inhibitor Screen, APTT; Mixing Studies - APTT | 24-72 hours |
| | Core Laboratory Referred to Commercial Laboratory | | | 3181008 | | Item | 85307-90 | | | | | APCR | 6-14-2017 | | | | 3.5 mL blood (0.5 mL citrated platelet poor plasma) | 6/15/2017 2:20 PM | Mira Davis | | APC RESIST | | | | Specimen hemolyzed
Hct >55% | This test cannot be added onto an existing sample. | 4.0 mL blood (2.0 citrated platelet poor plasma) | | RAPC; APC; APC Resistance | 5-7 working days |
| | Molecular Diagnostics/Cellular | | | | | Item | 88180 (x17) | | Mon-Fri, 0800-1600; weekends and holidays 0800-1630 pm by on-call basis. 85-5329. | | | ACUTE LEUK | | | | | 10 mL ACD blood, at least 1 mL ACD bone marrow, hypocellular patients may require extra sample. | 2/5/2015 3:45 PM | System Account | | ACUTE LEUKEMIA PROFILE | | Written interpretation is included with report | | | Do not refrigerate specimen. Tests require viable lymphocytes. Sample must be in laboratory within 24 hours of collection. Specimen should be submitted with a completed Patient Information Form. Contact the Flow Cytometry Laboratory at 312-942-8393 to obtain a form. | | METHOD - Immunophenotyping REFLEX TESTING - Depending upon results, further cell surface markers may need to be analyzed. This could include up to 6 additional markers. Cases of B-cell leukemia found by immunophenotyping may be followed up by JH PCR or light chain PCR. Cases of T-cell leukemia may be followed up by T-cell PCR. | Immunophenotyping; Flow cytometry | 1-3 days |
| | Core Laboratory | | Use to screen for HBS AG; detect carrier state. Screen for HBS AB; determine previous Hepatitis B infection and acquired immunity to Hepatitis B virus. Screen for acute Hepatitis B infection, recovery from Hepatitis B infection, or chronic Hepatitis B virus hepatitis. Differentiate diagnosis of acute hepatitis. Click here for more information about viral hepatitis. | | | Item | 80074; 87341 (HBS AG positives only) | | | Specimen should be transported as soon as possible. When transportation is delayed, refrigerate. | | AHP | 2-12-2015 | | | Enzyme immunoassay (EIA); enzyme-linked immunosorbent assay (ELISA).
| | 2/12/2015 7:56 AM | Melody I Adams | | | | No Hepatitis A IgM antigen detected; no Hepatitis B core IgM antibody detected; no Hepatitis B surface antibody detected; no Hepatitits C antibody detected. | | Excessive hemolysis, gross contamination of specimen, chylous serum, improper storage of specimen, inappropriate specimen container, insufficient specimen volume. | | | The panel includes the following tests: Hepatitis A virus IgM antibody (HAVAB IGM). Hepatitis B core IgM antibody (HBC IGM), Hepatitis B virus surface antigen (HBS AG), and Hepatitis C virus antibody (HCV AB). | Hepatitis Panel, Viral; AHP | 8 hours
|
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82017-90 | | | | | ACYL | 6-14-2017 | | | | 1.0 mL whole blood (0.2 mL plasma from green top) | 6/15/2017 2:21 PM | Mira Davis | | Acylcarnitine Profile | | | | | | 2 mL whole blood (1 mL plasma from green top) | | | one week |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82017 | | | | | ACYLCARNOB | | | | | Fill at least three spots. Blood can be collected in a green top (heparin) tube and spotted on a PKU card. | 2/5/2015 3:45 PM | System Account | | Acylcarnitine Profile, dried blood spots | | | | | | | | | one week |
| | Core Laboratory Referred to Commercial Laboratory | | | 3181572 | | Item | 85397-90, 85335-90, 83520-90 | | | | | AD13E | 6-14-2017 | | | | One 2.7 mL blue top (0.9 mL plasma) | 6/14/2017 11:22 AM | Mira Davis | | | | | | Specimen hemolyzed; Hct >55%; underfilled tube (QNS) | This test cannot be added onto an existing sample. | Two blue top (2.7 mL draw) (2.0 mL citrated platelet) | Includes Reflex testing if needed (inhibitor, antibody) | Von Willebrand Cleaving Protease Activity; VW CLEAV; VWF Cleaving Protease Activity; ADAMTS13 EVALUATION | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 84311, N-FDA | | | | | ADPLF | 8/3/2018 | | | Kinetic Spectrophotometric | | 8/16/2018 10:29 AM | Mira Davis | | | | | | | | |
An elevated level of adenosine deaminase (AD) in human serum, plasma, or select body fluids is used as surrogate marker for inflammation or infectious disease.
| | |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86255-90 | | | | | ADRAB | 9/6/17 | | | | 1.0 mL blood (0.5 mL serum) | 9/6/2017 11:01 AM | Sherry Bell | | | | | | | | 2.0 mL blood (1.0 mL serum) | | Adrenal Total Autoantibodies | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82024-90 | | | | | ACTH | | | | | 1.0 mL blood (0.5 mL EDTA plasma) | 2/5/2015 3:45 PM | System Account | | ADRENOCORTICOTROPIC HORMONE; ACTH | | | | | This test cannot be added onto an existing sample. | 2.0 mL blood (1.0 mL EDTA plasma) | | ACTH; Adrenal Corticotropin; Corticotropin | 5-7 working days |
| | Microbiology | Sealed sterile container w/no preservative | | | | Item | | | | | | CXAE; CXAES | 8/3/2018 | | | | | 8/15/2018 2:17 PM | Mira Davis | | | | | | | | | | | |
| | Core Laboratory | | | | | Item | 82042 | | Specimen accepted daily, 24 hours | | | FALB | 6-14-2017 | | | | | 6/14/2017 11:26 AM | Mira Davis | | FLUID ALBUMIN | | | | | Must specify fluid type on the requisition | | | Fluid Albumin | 1 hour |
| | Core Laboratory | | | | | Item | 82040 | | | | | ALB | 1-26-15 | | | | 0.4 mL blood (0.2 mL plasma) | 2/5/2015 3:44 PM | System Account | | ALBUMIN | | 0-3 years: 2.9-5.5 g/dL, 3 years to adult: 3.5-5.0 g/dL | | | | | | | Routine: 8 hours; stat: 1 hour |
| | Core Laboratory | | | | | Item | 84165 | | | | | A/G | | | | | 0.4 mL blood (0.2 mL serum) | 2/5/2015 3:44 PM | System Account | | ALBUMIN GLOBULIN RATIO; A/G RATIO | | 1.2-1.8; high ratio is usually clinically insignificant. | | | | | Test includes total protein, albumin, calculated globulin and calculated A/G ratio. | A/G Ratio | Routine: 8 hours |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82085-90 | | | | | ALDLA | 6-14-2017 | | | | 2.0 mL blood (1.0 mL serum) | 6/14/2017 11:27 AM | Mira Davis | | ALDOLASE | | | | | | 4.0 mL blood (2.0 mL serum) | | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82088-90 | | | | | ALDO | 6-14-2017 | | | | 1.0 mL blood (0.3 mL serum) | 6/14/2017 11:27 AM | Mira Davis | | ALDOSTERONE; ALDOST | | | | | | 2.0 mL blood (0.5 mL serum) | | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82088-90 | | | Keep refrigerated during collection. | | UALDO | 9/6/17 | | | | | 9/6/2017 11:00 AM | Sherry Bell | | URT ALDOSTERONE; U/ALDO | | | | | Requires a 24-hour urine collection | | | Urine Aldosterone | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 84080-90, 84075-90 | | | | | APISO | 9/6/17 | | | | 2.0 mL blood (1.0 mL serum) | 9/6/2017 10:56 AM | Sherry Bell | | ALKALINE PHOSPHATASE ISOENZYME | | | | | | 4.0 mL blood (2.0 mL serum) | | Alk Phos Isoenzymes; Fractionated Alk Phos | 5-7 working days |
| | Core Laboratory | | | | | Item | 84075 | | | | | ALP | 9/6/17 | | | | 0.4 mL blood (0.2 mL plasma)
| 9/6/2017 10:59 AM | Sherry Bell | | ALKALINE PHOSPHATASE; ALK PHOS; AP(ALK PHOS) | | 0-15 years: 80-250 units/L; 15 years and older: 30-125 units/L | | | | | | AlkP; Alk Phos; Phosphatase, Alkaline | Routine: 8 hours; stat: 1 hour |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86606(x2), 82785, 86331 | | | | | ABPA | | | | | 8 mL blood (4.0 mL serum) | 2/5/2015 3:45 PM | System Account | | ABPA | | Interpretation included with test results | | | Patient's information form must accompany specimen. Contact Core Laboratory to obtain form. | 10 mL blood (5.0 mL serum) | | ABPA Profile | 2-3 weeks |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86003-90 | | | | | ALMND | 9/6/17 | | | | 1.0 mL blood (0.3 mL serum) | 9/6/2017 1:05 PM | Sherry Bell | | Almond allergen | | | | | | 2.0 mL blood (1.0 mL serum) | | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82103-90 | | | | | A1ATP | 6-14-2017 | | | Immunoturbidimetric
| 1.0 mL blood (0.5 mL serum) | 6/14/2017 10:56 AM | Mira Davis | | ALPHA1 ANTITRYPSIN; A1AT | | | | Gross hemolysis, Grossly lipemic | | 2 mL blood (1.0 mL serum) | | A1AT, serum; AAT; Acute Phase Protein | 5-7 working days
|
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82104-90 | | | | | A1ATP | 9/6/17 | | | | 1.0 mL blood (0.5 mL serum) | 9/6/2017 10:46 AM | Sherry Bell | | ALPHA1 ANTITRYPSIN PHENO; A1AT PHENO | | | | | | 2.0 mL blood (1.0 mL serum) | | Pi Phenotype; Pi Typing; A1AT Phenotype | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82103-90 | | | | | QA1AT | 9/6/17 | | | | | 9/6/2017 10:32 AM | Sherry Bell | | Alpha-1-Antitrypsin, Stool | | | | | | | | A1AT, Stool | 5-7 working days |
| | Molecular Diagnostics/Genetics | | | | | Item | 82106-90 | | | | | AFPAM | 9/6/17 | | | | | 9/6/2017 10:15 AM | Sherry Bell | | ALPHA FETOPROTEIN AMNIOTIC or AFP-AM FLD | | | | | Provide patient's date of birth, completed weeks of gestation, and number of fetuses. Optimal screening gestational age is 16-18 weeks. Ranges exist for gestational ages between 14 and 21 weeks. AFP test request forms contain important patient information needed to calculate test results. A legible request form must accompany the specimen to the laboratory. Note: Maternal serum specimens must be drawn prior to amniocentesis. | | | AFP-AM FLD; Amniotic Fluid AFP | 5-7 working days |
| | Molecular Diagnostics/Genetics | | | | | Item | 82105 | | | | | AFP TUMOR | 1-28-2015 | | | CMIA (Chemiluminescent Microparticle Immunoassay) | 2 mL blood (0.5 mL plasma) | 2/5/2015 3:44 PM | System Account | | ALPHA FETOPROTEIN TUMOR or AFP TUMOR | | | | | | | | AFP Tumor Marker | 8 hours
|
| | Molecular Diagnostics/Cellular | | | | | Item | 83883-90 | | | | | A2MAC | 9/6/17 | | | | 1.0 mL blood (0.5 mL serum) | 9/6/2017 10:47 AM | Sherry Bell | | ALPHA2 MACROGLOBULIN; ALPHA2 MACRO | | | | Specimen hemolyzed; Hct >65% | | 2.0 mL blood (1.0 mL serum) | | A2M; Acute Phase Protein | 5-7 working days |
| | Molecular Diagnostics/Genetics | | | | Draw Monday through Thursday only. Sample must arrive at Mayo Labs within 72 hours of draw. | Item | 82657-90 | | | | | AGA | 9/6/17 | | | | | 9/6/2017 12:59 PM | Sherry Bell | | | | | | | | | | Anderson Fabry Disease; AGA; Alpha-Galactosidase A; Ceramide Trihexosidase; GLA Deficiency | 5-7 working |
| | Core Laboratory Referred to Commercial Laboratory | Red top tube or SST tube | | | | Item | 82657 | | | | | AGAS/Useful for Fabry disease diagnosis in males | 8/3/2018 | | | Fluorometric | 1 mL blood (0.5 mL serum) | 8/16/2018 10:33 AM | Mira Davis | | | | | | | | | | | 15 days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86003-90 | | | | | A TENIUS | | | | | 1.0 mL blood (0.3 mL serum) | 2/5/2015 3:45 PM | System Account | | Alternaria tenius Allergen | | | | | | 2.0 mL blood (1.0 mL serum) | Mold Allergen. Included in the Rast Inhalant Panel. | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82108-90 | | | | | ALMN | 9/6/17 | | | | | 9/6/2017 10:09 AM | Sherry Bell | | ALUMINUM; ALUM | | | | | | | | Al, Blood | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 80150 | | | | | AMIKT; AMIKP; AMIKR | 9/6/17 | | | | 0.4 mL blood (0.2 mL serum) | 9/6/2017 9:34 AM | Sherry Bell | | AMIKACIN POST DOSE; AMIK POST
AMIKACIN PRE DOSE; AMIK PRE
AMIKACIN RANDOM LEVEL; AMIK RND | | | | Specimen collection time not recorded on requisition; no SST tubes | Requisition must be marked random, pre- or postdose; include date and time specimen drawn. Indicate specimen type if not blood. | | Draw Pre just prior to next dose; Draw Post - at end of 60 min IV infusion or 30 minutes after the end of 30 minutes IV infusion or 60 minutes after IM dose. | Amikin.; Amikacin, Post; Amikacin, Pre; Amikacin, Random | Routine: 5-7 working days
Stat: 4-6 hours |
| | Molecular Diagnostics/Genetics | | | | | Item | 82139 | | | | | AA QT | | | | | | 2/5/2015 3:44 PM | System Account | | AMINO ACID QUANTITATIVE BL; AA QT
| | Provided with patient report. Age dependent | | | | | | Blood Amino Acid, Quantitative; Plasma Amino Acids; Quantitative Amino Acids, Plasma | 5 days |
| | Molecular Diagnostics/Genetics | Chemically clean urine collection bottle | | | | Item | 82139 | | | | | U/AA QT | | | | | 10 mL, indicate total volume (mL)/24 hours | 2/5/2015 3:44 PM | System Account | | | | Provided with patient report. Age dependent. | | | | | | Quantitative Amino Acids, Urine; Urine Amino Acids | 5 days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82492-90 | | | | | AMIOD | | | | | 2.0 mL blood (1.0 mL serum) | 2/5/2015 3:45 PM | System Account | | AMIODARONE; AMIOD | | | | SST tubes not acceptable. | | 4.0 mL blood (2.0 mL serum) | | Cordarone | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 80335-90 | | | | | AMITI | 9/6/17 | | | | 3.0 mL blood (1.0 mL serum) | 9/6/2017 9:32 AM | Sherry Bell | | AMITRIPTYLINE | | | | SST tubes not acceptable | | 4.0 mL blood (2.0 mL serum) | | Elavil.; Endep.; Etrafon.; Triavil. | 5-7 working days |
| | Core Laboratory | | | | | Item | 82140 | | | Specimen must be placed on ice and transported to the laboratory immediately after collection. | | NH3 | 7/10/2023 | | | | 0.4 mL blood (0.2 mL plasma) | 7/10/2023 1:26 PM | Mira Davis | | | | Male: 65-107 µg/dL; female: 58-94 µg/dL | | Specimen not delivered on ice immediately after collection. | Caution: Blood ammonia increases rapidly at room temperature. When specimens are collected at a remote site, results may be elevated due to delay in testing. This test cannot be added onto an existing sample.
| | | Blood Ammonia, Blood NH3; NH3; NH4 | 1 hour |
| | Core Laboratory | | | | | Item | 82145 | | | | | U/DS | | | | FPIA (Fluorescence Polarization Immunoassay)
| | 2/5/2015 3:44 PM | System Account | | | | | | | Do not use results for medicolegal purposes. For medicolegal purposes, specimens should be collected using chain-of-custody precautions and screening results should be confirmed using gas chromatography/mass spectrometry. Chain-of-custody and confirmation are not part of the urine drug screen and are not provided by this laboratory. | | This test is part of urine drug screen, and is not available as a separate test. The urine drug screen for the amphetamine group is subject to occasional false positive results from non-prescription sympathomimetric amines (e.g., pseudoephedrine, phenylpropanolamine). If this laboratory obtains a positive amphetamine result, the requesting physician will be asked to decide if the specimen should be sent out for confirmation by gas chromatography-mass spectrometry. | | Routine 4 hours; stat: 1 hour |
| | Microbiology | | Patients in whom Neisseria gonorrhoeae or Chlamydia trachomatis is detected are reported to the City of Chicago Board of Health. This is mandated by law. | 3421089 | Endocervical: Remove excess mucus from the cervical os and surrounding mucosa using cleaning swab (white shaft swab). Discard the swab. Insert the specimen collection (blue shaft) swab into the endocervical canal. Rotate the swab for 10 -30 seconds to ensure adequate sampling. Withdraw the swab carefully to avoid any contact with the vaginal mucosa. Insert the swab into the Aptima transport medium. Break off the swab shaft to fit the tube, then cap the tube, tightly.
Urethra: Patients should not have urinated for 1 hour prior to sample collection. Collect the urethral exudate or insert the swab from the collection kit 2- 4 cm into the urethra. Rotate the swab gently using sufficient pressure to ensure the swab comes in to contact with all urethral surfaces. Allow the swab to remain inserted for 2-3 seconds. Withdraw swab and insert into Aptima transport medium. Break off the swab shaft to fit the tube, then cap the tube.
See SPECIAL INSTRUCTIONS and ADDITIONAL INFORMATION for urine. | Item | 87491, 87591 | | | Specimen should be transported as soon as possible.¿ When transportation is delayed, leave at room temperature. | | PRB CHL/GC | 7-3-2013 | A negative urine result for Neisseria gonorrhoeae from a female patient has a lower sensitivity than does an endocervical or vaginal swab result (91.3 % for urine, versus 99.3 % for endocervical swabs) (Gaydos CA et al. Journal Clinical Microbiology, 2003; 41:304-9). Results obtained by nucleic acid amplification probe testing should not be used for medicolegal purposes. Neisseria gonorrhoeae or Chlamydia trachomatis cultures must be performed in such cases. | | Transcription Mediated Amplification and non isotopic nucleic acid probe testing
| One (blue) swab in Aptima Gen-Probe transport medium 20 -30 mL urine in sterile urine cup 2 ml urine added to Aptima urine transport tube | 2/5/2015 3:45 PM | System Account | | Amplified Probe Chlm and GC
| | No Neisseria gonorrhoeae or Chlamydia trachomatis detected. | | Improper collection and/or transport of specimen (ie. Gen-Probe Aptima collection kit and/or transport medium not used); more than one swab submitted in transport container; specimens from sites other than endocervix, urethra, or urine; insufficent quantity of specimen; Gen-Probe Aptima urine tube over or underfilled. | The specific anatomic site of the specimen MUST be specified on the order or requisition.
Additional Collection Information:
Urine: Collection for male and female Patient should not have urinated for 1 hour prior to specimen collection. Direct patient to provide approximately 20 - 30 ml of initial stream into a urine collection cup free of any preservatives. Collection of larger volumes of urine may result in specimen dilution that may reduce test sensitivity. Female patients should NOT cleanse labial area prior to providing specimen. Remove cap from Aptima urine transport tube and transfer 2 ml of urine into urine specimen transport tube using disposable pipette provided. The correct volume of urine has been added when fluid level is between black fill lines on urine specimen transport tube label. Re-cap urine specimen transport tube tightly. Alternatively, urine specimens still in the primary collection container may be submitted to the laboratory within 24 hours of collection. | Endocervical, or urethral swab; urine | The Aptima Combo 2 Assay is a target amplification nucleic acid probe test for the detection of rRNA from Chlamydia trachomatis and/or Neisseria gonorrhoeae. | PCR, TMA or Amplification for Chlamydia trachomatis or Neisseria gonorrhoeae; Gen-Probe for Neisseria gonorrhoeae or Chlamydia trachomatis; DNA Probe for Neisseria gonorrhoeae or Chlamydia trachomatis; Gonorrhoeae by DNA Probe; Chlamydia by DNA Probe | 24-72 hours
|
| | Core Laboratory | | | | | Item | 82150 | | Specimen accepted daily, 24 hours | | | FAMY | 8/3/2018 | | | | | 8/3/2018 11:19 AM | Jaime Desantiago | | FLUID AMYLASE
| | | | | Must specify fluid type on the requisition. | | | Fluid Amylase | 1 hour |
| | Core Laboratory | | | | | Item | 82150 | | | | | AMY | 1-27-2015 | | | |
0.4 mL blood (0.2 mL plasma)
| 2/5/2015 3:44 PM | System Account | | AMYLASE; AMY | | | | | | | | | Routine: 8 hours; stat: 1 hour |
| | Core Laboratory | | | | | Item | Random = 82150; Timed = 82150, 81050 | | Specimen accepted daily, 24 hours
| Keep urine refrigerated during collection. | | UAMYR (random urine); UAMY (24-hour urine) | 8/3/2018 | | | | Random urine: 1 mL
Timed urine: Submit entire collection to the laboratory
| 8/15/2018 2:06 PM | Mira Davis | | Urine Amylase Random; Urine Amylase Timed
| | Random urine: None established
Timed urine: 35-560 IU/24 hours
| | | For timed urine collection, instruct patient to void at the beginning of collection period and discard the specimen. Collect all urine including final specimen voided at the end of collection period. Containers must be labeled with the patient's full name, room number, date and time collection started, and date and time collection finished. | | To assess the completeness of a timed urine collection a timed urine creatinine will be performed. | Urine Amylase | 8 hours |
| | Core Laboratory | | | | | Item | 82150; 82150; 82565; 82570 | | | Keep urine refrigerated during collection. | | U/AM/CRCLR | | | | | 4 mL blood (2 mL serum); submit entire urine collection to the laboratory. | 2/5/2015 3:44 PM | System Account | | AMY CREAT RATIO; URT AMYLASE CREATINE CLEAR RAT; U/AM/CRCLR | | | | | Blood amylase and creatinine should be ordered and sent to the laboratory during urine collection. Failure to send blood amylase and creatinine is cause for rejection. For timed urine collection, instruct patient to void at the beginning of collection period and discard the specimen. Collect all urine including final specimen voided at the end of the collection period. | Blood (serum) and timed or random urine | Test includes: serum amylase, urine amylase, serum creatinine, urine creatinine, amylase/creatinine clearance ratio | Amylase/Creatinine Clearance | 24-48 hours |
| | Core Laboratory | | | | | Item | 82150; 82570 | | | Keep urine refrigerated during collection. | | U/AM/CR/RA | | | | | Submit entire urine collection to the laboratory. | 2/5/2015 3:44 PM | System Account | | URT AMYLASE CREATINE RATIO; U/AM/CR/RA | | 70-700 units of amylase/g creatinine | | | For a timed urine collection, instruct patient to void at the beginning of collection period and discard the specimen. Collect all urine including final specimen voided at the end of the collection period. | | Test includes urine creatinine, urine amylase, amylase/creatinine ratio. | Amylase/Creatinine Clearance | 24-48 hours |
| | Core Laboratory | | | | | Item | 86038 | | | | | ANASC | 11-30-2017 | | | | 1 mL blood (0.5 mL serum)
| 11/30/2017 3:18 PM | Julieth Hernandez | | | | | | Hemolysis, gross contamination, icteric, lipemic
| | | If ANA screen is positive, reflexing testing is done: ANA-IFA, DNA, ENA, SSAB
| ANA EIA; Antinuclear Antibody by Enzyme Immunoassay | 1-4 days
|
| | Microbiology | | | | The specimen of choice is an aspirate or tissue, NOT a swab. Specimens are to be collected from a site prepared utilizing aseptic technique. Overlying and adjacent areas must be carefully prepared to eliminate surface (normal flora) anaerobes. Ideally, material is obtained by needle aspiration through an intact surface, which has been cleaned with antiseptic, then placed directly into the BBLTM Port-A-Cul Transport System. Sampling of open lesions is enhanced by deep aspiration using a sterile plastic catheter. Curetting of the base of an open lesion is optimal. If irrigation is necessary, nonbacteriostatic sterile saline may be used. When a syringe is used to obtain the specimen, ALL air should be expelled after which the specimen should be injected into a BBLTM Port-A-Cul Transport System. Swabs should be used as a last resort due to the small volume of specimen obtainable by this method. If a swab must be used, sample the advancing margin of the lesion and abscess walls firmly. Do NOT sample pus or exudate ONLY. Insert the swab containing the sample about 1 cm from the bottom of the transport tube. Break off the swab shaft and secure the lid tightly. Contamination with normal flora from skin or other body sources MUST be avoided since colonizing bacteria not involved in the infectious process may be introduced into the sample. | Item | 87075 | | | Avoid exposure to atmospheric oxygen. Specimen should be transported as soon as possible. When transportation is delayed, leave at room temperature. Do NOT refrigerate. | | CXAN | 8/3/2018 | A specimen received in anaerobic transport devices is not suitable for routine fungal or mycobacterial cultures. If more than three anaerobic isolates are present, the Bacteroides fragilis group, Clostridium perfringens, and Actinomyces species will be the only isolates identified. Anaerobic susceptibility testing is NOT performed routinely. Should susceptibility testing be required, call the Clinical Microbiology laboratory at (312)942-5452. | | Conventional culture utilizing media specifically formulated for anaerobic isolation.
| Varies depending upon the body site. One swab in BBLTM Port-A-Cul Transport System; 0.5-5 ml pus from aspirated site, small piece of tissue, 0.5-10 ml fluid, sterile gauze which has been collecting wound drainage | 8/3/2018 11:27 AM | Jaime Desantiago | | CXAN
| | No growth of Actinomyces species or anaerobic bacteria | | Inappropriate specimen container, insufficient specimen volume, refrigerated specimen. Specimens from sites which have anaerobic bacteria as normal flora will routinely be rejected. | Order or requisition MUST state that the culture is being performed to rule out the presence of Actinomyces species. It is recommended that the Clinical Microbiology Laboratory be notified at (312)942-5452 prior to specimen submission. Avoid exposure to atmospheric oxygen. Specimens should be transported as soon as possible. When transportation is delayed, leave at room temperature. Do NOT refrigerate. The specific anatomic site of the culture MUST be specified on the order or the requisition. Distinguish between surface and deep or surgical specimens. | Aspirate, tissue, body fluid, draining sinus tract, or other material appropriately obtained for anaerobic culture. | Test includes culture for anaerobic organisms and in particular Actinomyces species, as well as, macroscopic and microscopic examination for sulfur granules. Other isolated organisms (i.e. aerobes, yeast, etc.) may be referred for identification and/or susceptibility testing if medically indicated AND a separate culture procedure has NOT yielded the same organism(s). | Actinomycosis; Anaerobic Culture, Actinomycosis | Cultures are examined every 48 hours. Preliminary reports available after 48 hours. Culture reports of no growth will be issued after 10 days. Completion of culture reports may take 10-12 days after receipt of the specimen, depending upon the nature of the microorganisms isolated.
|
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86021 x3 | | | | | PANCA | 8/3/2018 | | | | | 8/15/2018 2:01 PM | Mira Davis | | ANTINEUTROPHIL CYTOPLASMIC AB; ANCA
| | | | Excessive hemolysis, gross contamination of specimen, chylous serum, improper storage of specimen, inappropriate specimen container, insufficient specimen volume. | | | Testing for anti-neutrophil cytoplasmic antibodies (P-ANCA and/or C-ANCA) has been found to be useful in establishing the diagnosis of suspected vascular diseases, inflammatory bowel disease, as well as other autoimmune diseases. Test code 70159.
| ANCAS; CANTI; PANTI; APANT; MPOAB; PR3AB | 5-7 working days
|
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86003-90 | | | | | MISC | 8/3/2018 | | | | 1.0 mL blood (0.2 mL serum) | 8/3/2018 11:03 AM | Jaime Desantiago | | Anchovy Allergen | | | | | | 2.0 mL blood (1.0 mL serum) | | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82157-90 | | | | | ANDRS | 8/3/2018 | | | | 1.0 mL blood (0.4 mL serum) | 8/3/2018 11:03 AM | Jaime Desantiago | | ANDROSTENEDIONE; ANDROSTENE | | | | SST tubes not acceptable | | 2.0 mL blood (1.0 mL serum) | | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82157-90 | | | Must send to lab within one hour of collection. | | MISC CHEM | | | | | 0.5 mL blood (0.2 mL serum) | 2/5/2015 3:45 PM | System Account | | | | | | SST tubes not acceptable. | | 1.0 mL blood (0.5 mL serum) | | | 5-7 business days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82164-90 | | | | | ACE | 8/3/2018 | | | | 1 mL of blood (0.5 mL serm) | 8/3/2018 11:09 AM | Jaime Desantiago | | ANGIOTENSIN CONVERTING ENZYME; ACE | | | | | | 2 mL of blood (1 mL of serum) | | ACE | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | 3181375 | | Item | 82164-90 | | | | | CACE | 8/3/2018 | | | Kinetic | | 8/3/2018 11:09 AM | Jaime Desantiago | | ACE CSF | | | | | | | | CSF ACE; Angiotensen Converting Enzyme, CSF; ACE, CSF | 5-7 working days |
| | Microbiology | | Antibiotics not yet FDA approved may be tested on a research only basis. Results are interpreted as susceptible (S), intermediate (I), or resistant (R). MIC`s (minimum inhibitory concentrations) may also be reported depending upon the isolate and/or the method used for testing. | | | Item | 87186 or 87174 or 87181 (each drug) | | | | | Not orderable in LIS | 5-27-2014 | Nonviable microorganisms. | | Kirby-Bauer; E-test; automated minimum inhibitory concentrations.
| | 2/5/2015 3:45 PM | System Account | | Not orderable in POE
| | Variable, depending upon the organism and the antibiotic. | | Organism discarded prior to physician request for special antimicrobial testing, antibiotic requested not available, nonviable organism. | A specified battery of antibiotics are routinely tested. If additional antibiotics are requested, consult the Clinical Microbiology Laboratory at (312)942-5452 within 7 days of submission of specimen for culture. | Organism isolated from patient`s specimen (pure culture isolate) | The test includes routine testing of a variety of antibiotics against an isolated organism. The types of antibiotics tested depends on the body site, as well as, the organism identification. | E Test Susceptibility Testing, Kirby-Bauer | 24-72 hours after isolation of bacterium to be tested
|
| | Blood Bank | | | | Special Labeling Requirements: The content of each sample label must include the patient’s full name and medical record number, the phlebotomist’s initials, the date and time the sample was collected and, for nurse draws, the initials of a second medical professional who has confirmed that the sample came from the patient whose name is on the label; the computer label must have this same information plus an accession number and the tests ordered. Samples collected by a phlebotomist using the Soft ID Patient Identification system does not require a second initial. Samples collected by anyone using a manual requisition will require two initials as described above.
| Item | 86870 | | | | | PANEL | 08/19/2021 | | | | | 8/19/2021 9:54 AM | Mira Davis | | | | | | | Test is automatically performed on all positive antibody screens. | Blood (red cells and plasma)
| | Atypical Red Blood Cell Antibody Identification; Irregular Red Blood Cell Antibody Identification; Red Blood Cell Antibody Identification Panel | 2-4 hours depending on complexity of antibody (sometimes longer) |
| | Blood Bank | | Antibody identification will automatically be performed if test is positive. | | Special Labeling Requirements: The content of each sample label must include the patient’s full name and medical record number, the phlebotomist’s initials, the date and time the sample was collected and, for nurse draws, the initials of a second medical professional who has confirmed that the sample came from the patient whose name is on the label; the computer label must have this same information plus an accession number and the tests ordered. Samples collected by a phlebotomist using the Soft ID Patient Identification system does not require a second initial. Samples collected by anyone using a manual requisition will require two initials as described above.
| Item | 86850, 86900, 86901 | | | | | T/S | 8/19/2021 | | | | | 8/20/2021 6:41 AM | Mira Davis | | TYPE AND SCREEN; CLOT; T/S | | | | | | Blood (red cells and plasma) | | IAT; Indirect Antiglobulin Test; Indirect Coombs`; Screen for Atypical RBC Antibodies; Screen for Irregular RBC Antibodies | 2 hours |
| | Blood Bank | | | | Special Labeling Requirements: The content of each sample label must include the patient’s full name and medical record number, the phlebotomist’s initials, the date and time the sample was collected and, for nurse draws, the initials of a second medical professional who has confirmed that the sample came from the patient whose name is on the label; the computer label must have this same information plus an accession number and the tests ordered. Samples collected by a phlebotomist using the Soft ID Patient Identification system does not require a second initial. Samples collected by anyone using a manual requisition will require two initials as described above.
| Item | 86886 | | | Remaining plasma will be frozen in case subsequent parallel titers are required. | | TITER | 08/19/2021 | | | | | 8/19/2021 10:06 AM | Mira Davis | | | | An increase > 2 dilutions or a score change > 10 in parallel titers is significant | | | | | | Atypical Antibody Titer; Irregular Antibody Titer; Red Cell Antibody Titer; Rh Titer | 2 hours |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86215-90 | | | | | ADB | | | | | 1.0 mL blood (0.4 mL serum) | 8/7/2019 1:16 PM | Mira Davis | | ADB | | | | | | 2.0 mL blood (1.0 mL serum) | | ADB; ADNase-B; Anti-DNase-B Titer; Antistreptococcal DNase-B Titer; Streptodornase | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 84588-90 | | | Deliver to Core Laboratory immediately. | | AVP | 6-14-2017 | | | | 4.0 mL EDTA whole blood (2.5 mL EDTA plasma) | 6/14/2017 11:23 AM | Mira Davis | | ADH | | | | | This test cannot be added onto an existing sample. | 8.0 mL EDTA whole blood (4.0 mL EDTA plasma) | | ADH; Arginine Vasopressin; AVP; Vasopressin | 5-7 working days |
| | Core Laboratory | SST Tube or Red top tube 4mL
| | | | Item | 86225 | | | | | DNA | 11-30-2017 | | | | 1.0 mL blood (0.5 mL serum) | 12/1/2017 1:58 PM | Julieth Hernandez | | ANTI DNA; ANTI DS DNA; DNA (DNA DS DNA); DS DNA AB
| | | | Hemolysis, icteric, lipemic, grossly contaminated | | 4.0 mL blood (2.0 mL serum) | | DS-DNA; DNA Antibodies; Double-Stranded DNA (Native) Antibody | 1-4 days
|
| | Core Laboratory | | | | | Item | 86235 x2 | | | | | ENA | 11-30-2017 | | | | 1.0 mL blood (0.5 mL serum) | 12/1/2017 2:01 PM | Julieth Hernandez | | ANTI ENA; ENA; SM; SM+RNP
| | Sm: NEGATIVE <1.0 AI (antibody index)
Sm/RNP: NEGATIVE <1.0 AI | | Hemolysis, gross contamination, icteric, lipemic | | | | Antiextractable Nuclear Antigen; ENA; Extractable Nuclear Antigen; Anti-RNP; Anti-SM; RNP Antibodies; Ribonuclearprotein Antibodies; SMITH AB | 1-4 days
|
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86215-90 | | | | | ADB | | | | | | 2/5/2015 3:45 PM | System Account | | ADB | | | | | | | Refer to Dnase B Antibody | Antistreptococcal Hyaluronidase Titer - no longer available | 5-7 days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82397 | | | | | AHMA | 8/3/2018 | | | | 1.0 mL blood (0.5 mL serum) | 8/3/2018 2:35 PM | Jaime Desantiago | | | | | | | | 1.0 mL blood (0.5 mL serum) | | Mullerian Inhibiting Substance | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86021-90 | | | | | GRANULO AB | | | | | 1 mL blood (0.1 m serum) | 2/5/2015 3:45 PM | System Account | | | | | | | | 2 mL blood (1.0 mL serum) | Refer to Granulocyte (Neutrophil) Antibody | | 7-10 days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 85613-90, 86146-90 (x3), 86147-90 (x3), 86148-90 (x3) | | | Specimen must be delivered to the laboratory immediately. | | ANTIPHOS | 2-27-2014 | | | | | 2/5/2015 3:45 PM | System Account | | | | | | | Heparinized plasma is a cause for rejection. | 7 tubes - 2.7 mL blue top | Test includes: dRVVT, Cardiolipin IgG, IgM, IgA, and Phosphatidylserine IgG, IgM, IgA, Beta-2 Glycoprotein I IgG, IgM, IgA | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86226-90 | | | | | SSDNA | 9-18-2019 | | | | 1.0 mL blood (0.5 mL serum) | 6/18/2019 11:24 AM | Mira Davis | | SS-DNA | | | | | | 2 mL blood (1.0 mL serum) | | Single-Stranded DNA Antibodies; SS-DNA; DNA-Single Stranded Antibodies | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86060-90 | | | | | ASO | 4-13-2015 | | | | 1.0 mL blood (0.5 mL serum) | 4/13/2015 9:26 AM | Melody I Adams | | ANTISTREPTOLYSIN O TITER; ASO | | | | | | 2.0 mL blood (1.0 mL serum) | | ASLO; ASO; ASO Titer | 5-7 working days |
| | Core Laboratory | | | | | Item | 85300 | | | Transport the specimen to the laboratory as soon as possible. Specimen MUST be received within 4 hours after collection. | | AT3 ACT | 10/12/2011 | | | | 1 mL plasma from properly filled tube | 2/5/2015 3:44 PM | System Account | | ANTITHROMBIN III FUNCTIONAL; AT3 ACT | | | | Specimen hemolyzed; Hct >55% | Transport the specimen to Specimen Receiving as soon as possible. Blood should arrive in the Core Laboratory within 4 hours of drawing.This test cannot be added onto an existing sample more than 4 hours old.
| | | Antithrombin III Assay; Antithrombin III Functional; Functional Antithrombin III; Heparin Cofactor Activity; Serine Protease Inhibitor; Antithrombin | |
| | Core Laboratory Referred to Commercial Laboratory | | | 3181338 | | Item | 85301-90 | | | | | ATIII ANT | | | | | 3.5 mL blood (1.0 mL citrated platelet poor plasma); pediatric tubes must be fully drawn. | 2/5/2015 3:45 PM | System Account | | ANTITHROMBIN III ANTIGEN; ATIII ANT | | | | Specimen hemolyzed; Hct >65% | | 4 mL blood (2.0 mL citrated platelet poor plasma) | | Heparin Cofactor Antigen | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82172-90 | | | | | APO A1 | | | | | 1.0 mL blood (0.5 mL serum) | 2/5/2015 3:45 PM | System Account | | APOLIPOPROTEIN A1 | | | | lipemic, icteric, and hemolyzed samples are not acceptable. | Patient should fast for 12 hours prior to blood draw. | 2.0 mL blood (1.0 mL serum) | | APO A-1; APO A1 | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82172-90 | | | | | APO B | | | | | 1.0 mL blood (0.5 mL serum) | 2/5/2015 3:45 PM | System Account | | APOLIPOPROTEIN B | | | | moderately lipemic, icteric, or hemolyzed specimens are not acceptable. | Patient should fast for 12 hours prior to blood draw. | 2.0 mL blood (1.0 mL serum) | | | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 83890, 83892, 83894, 83898, 83912 | | | | | APO E | | | | | 0.5 mL EDTA whole blood at room temperature | 2/5/2015 3:45 PM | System Account | | APOLIPOPROTEIN E GENOTYPE; APO E | | | | | Draw Sunday through Thursday only. Contact lab for history form. | 3.0 mL EDTA whole blood at room temperature | | APO E Genotyping | 7-10 days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82175-90 | | | | | AS | | | | | 2.0 mL Navy Blue EDTA whole blood | 2/5/2015 3:45 PM | System Account | | ARSENIC; AS | | | | | | 7.0 mL Navy Blue EDTA whole blood | | AS | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82175-90 | | | Keep refrigerated during collection. | | U/AS | | | | | | 2/5/2015 3:45 PM | System Account | | URT AS; U/AS | | | | Do not use hydrochloric acid (HCl) preservative. | | | | Urine Arsenic | 5-7 working days |
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 86003-90 | | | | | A. FUM | | | | | 1.0 mL blood (0.3 mL serum) | 2/5/2015 3:45 PM | System Account | | Aspergillus fumigatus allergen | | | | | | 2.0 mL blood (1.0 mL serum) | Mold allergen. Included in the Rast Inhalant Panel. | | 5-7 working days |
| | Core Laboratory | Sterile specimen container (provided by lab) | | | | Item | 89240 | | Monday-Thursday, 0700 am - 0900 am with appointment
| Specimen should ideally be produced in lab. | | ART | 4-14-2015 | | | | | 4/14/2015 11:36 AM | Melody I Adams | | ASSISTED REPRODUCTIVE TECHNIQUE (Semen Analysis with Morphology + 24 Motility & Viability Assessment)
| | | | Improper collection, incomplete requisition information | Call Andrology office at x34024 to schedule appointments. Appointment should be scheduled at least 3 days in advance. You must receive a Medical Record Number in Room 439 Pro Bldg II prior to producing semen specimen. Semen specimens are produced in the Andrololgy Lab, Suite 119 Pro Bldg I. Please allow 2-3 days of sexual abstinence prior to specimen collection. | | | | 3-5 business days |
| | Core Laboratory | | Positive ANA Screens are reflexed to ANA titer, DNA, ENA, SSAB. | | | Item | | | C3, C4, CRP - Daily, 24 hours | | | AIP | 11-30-2017 | | | | | 11/30/2017 2:52 PM | Julieth Hernandez | | AUTOIMMUNE PROFILE; AIP | | | | | | | Profile includes C3, C4, RF, CRP, ANASC. Tests available individually. | AIP; Autoimmune Profile; Collagen Profile | 1-3 days |
| | Blood Bank | | | | Special Labeling Requirements: The content of each sample label must include the patient’s full name and medical record number, the phlebotomist’s initials, the date and time the sample was collected and, for nurse draws, the initials of a second medical professional who has confirmed that the sample came from the patient whose name is on the label; the computer label must have this same information plus an accession number and the tests ordered. Samples collected by a phlebotomist using the Soft ID Patient Identification system does not require a second initial. Samples collected by anyone using a manual requisition will require two initials as described above. | Item | 86920 | | | | | AUTO XM | 08/19/2021 | | | | | 8/19/2021 10:53 AM | Mira Davis | | | | | | | Indicate on requisition 'Autologous.' | | | Autotransfusion; Transfusion, Autologous | Three working days past donation till available for transfusion. Available for transfusion 1 hour after receipt of transfusion request or approximately 2 hours if frozen. |
| | Blood Bank | | | | | Item | 36520; 86999; 86999 | | | Maintain specimen at room temperature. | | BM PHER; BM TUMOR; BM CRYO | | | | | 1000-4000 mL; varies depending upon CBC | 2/5/2015 3:45 PM | System Account | | | | | | | Must be arranged in advance | | | Autologous Bone Marrow Concentration; Bone Marrow Processing and Freezing, Autologous | 10-14 hours |
| | Blood Bank for processing of SST samples only; AND Core Laboratory for HIV testing (if AEYEG ordered) | (2) full SST tubes; AND (1) Serum Red Top Tube for HIV testing (if AEYEG ordered)
| | | | Item | | | | See Special Instructions | | AEYE; (OR) AEYEG | 07/13/2017 | | | | | 7/14/2017 9:06 AM | Mira Davis | | | | | | |
Patient is required to have an order for the Autologous Serum Eye Drops and will be instructed to call the POB 439 Outpatient Phlebotomy (312-942-3221) to schedule an appointment for collection. Appointments are taken only Monday through Friday, from 7am to 2:30pm to ensure the lab has enough time to prepare the sample. The patient will wait at the POB lab for the sample and the patient will transport the sample to Mark's Drugs Pharmacy.
Patients are required to have an HIV test performed once every 6 months. These results must be faxed to Mark's Drugs Pharmacy at 630-529-3429. It is the ordering physicians’ responsibility to order the correct test. One of the following tests must be ordered in Epic by the ordering clinician:
1. AEYE - Auto eye drop collection only
2. AEYEG - Auto eye drop collection plus HIV testing
COLLECTION PROCEDURE
1. Follow all appropriate collection procedures to identify the patient, identify a vein and prepare the site for collection.
2. Collect two full 7mL Gold SST tubes and label appropriately. This procedure requires serum, so only Gold SST tubes can be collected - Red Top Tubes cannot be substituted for the Gold SST in this procedure. If the patient also requires the HIV test, collect a full 7mL Red Top Tube.
3. Tube the Gold SST samples along with the requisition and all pertinent labels immediately after collection to the Blood Center, tube station 208. Place a call to 2-5920 to notify the Blood Bank that an Auto Serum Eye Drop sample is on its way.
4. Tube the Red Top Tube directly to the Core Lab for HIV testing (if applicable).
SAMPLE PROCESSING
1. Immediately upon receipt the sample must be checked for appropriate labeling. Confirm the patient information on the sample matches the requisition.
2. Samples must be centrifuged within one hour of collection. This will be the responsibility of the expeditor.
a. Centrifuge for 15 minutes at 2200 - 2500 RPM
b. Set a 15 timer as a reminder to pull the sample from the centrifuge
3. Once the sample is centrifuged, it must be kept refrigerated. Processing should happen as soon as possible after centrifugation.
4. Hemolyzed samples are rejected. If the sample is hemolyzed, call the POB Outpatient Phlebotomy Lab and inform them so they can inform the patient. The phlebotomist may attempt to redraw the samples.
5. Verify there is at least 4mL of serum available between the two SST tubes - if not call the POB Outpatient Phlebotomy Lab and ask them to collect one additional SST vial.
6. Spun samples must be packed on ice immediately after centrifugation
a. Protect the sample vials and labels by placing those alone in a plastic bag
b. Place those vials inside a bag with one, moderately filled small scoop of ice.
c. Place that bag inside one more plastic bag for added protection.
7. Tube the vials back to the POB Outpatient Lab and call them to let them know they are on the way.
8. POB Staff will hand the vials back to the patient who will then transport to Mark's Drugs Pharmacy.
| | The Rush Section of Cornea and External Diseases
on occasion has the need to order eye drops which are prepared from the
patient's own serum. The purpose of this procedure is to prepare the serum that
will be sent to Mark's Drugs Pharmacy, who will then prepare the eye drops from
the patient's serum. | | 30 minutes for SST serum specimen processing; AND 8 hours for HIV testing (if AEYEG ordered) |
| | Core Laboratory | | | | | Item | 82607, 82746 | | | | | B12 | 1-28-2015 | | | Chemiluminescent
| 1.0 mL blood (0.5 mL plasma)
| 2/5/2015 3:44 PM | System Account | | VITAMIN B12 | | | | | | 2.0 mL blood (1.0 mL plasma)
| | B12; Cobalamin; Vitamin B12 | 8 hours
|
| | Core Laboratory Referred to Commercial Laboratory | | | | | Item | 82232-90 | | | | | RU/B2 MICR | | | | | | 2/5/2015 3:45 PM | System Account | | Urine B2 Microglobulin Random | | | | | | | | Urine B2 Microglobulin | 5-7 working days |